SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Kieseier BC)
 

Sökning: WFRF:(Kieseier BC) > An assay to quantif...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00002685naa a2200325 4500
001oai:prod.swepub.kib.ki.se:128082502
003SwePub
008240701s2013 | |||||||||||000 ||eng|
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1280825022 URI
024a https://doi.org/10.1177/13524585134754892 DOI
040 a (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Warnke, C4 aut
2451 0a An assay to quantify species-specific anti-JC virus antibody levels in MS patients
264 c 2013-02-06
264 1b SAGE Publications,c 2013
520 a The StratifyJCV® test is a qualitative assay to classify MS patients as anti-JC virus (JCV) antibody positive or negative. Quantification of anti-JCV antibody levels in serum and cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients might add to the progressive multifocal leukoencephalopathy (PML) risk assessment.Objective:The objective of this study is to test sera of patients in a quantitative anti-JCV antibody assay, and to compare the results with preexisting data from the StratifyJCV® test.Methods:Sera of a total of 175 MS patients and matched non-MS-controls were tested for anti-JCV antibodies using glutathione S-transferase-tagged-VP1 as antigen. Antibody reactivity was quantified in arbitrary units using human immunoglobulin as standard.Results:The comparison of our assay with StratifyJCV® showed good inter-assay agreement (kappa 0.6), and strong correlation for antibody reactivity ( r2= 0.94). Discordant samples had low-reactive positivity, and a higher proportion (13% vs. 4%) tested positive in the StratifyJCV® test only.Conclusions:The method presented is a tool for the reliable quantification of anti-JCV antibodies, which demonstrates good agreement with results from StratifyJCV®. In contrast to StratifyJCV®, we pre-adsorbed all of the sera with BK virus (BKV) VP1 protein to reduce cross-reactivity. This step may account for a higher species-specificity of our assay. As such, our assay might be a promising additional tool for PML risk assessment.
700a Pawlita, M4 aut
700a Dehmel, T4 aut
700a Posevitz-Fejfar, A4 aut
700a Hartung, HP4 aut
700a Wiendl, H4 aut
700a Kieseier, BC4 aut
700a Adams, O4 aut
773t Multiple sclerosis (Houndmills, Basingstoke, England)d : SAGE Publicationsg 19:9, s. 1137-1144q 19:9<1137-1144x 1477-0970x 1352-4585
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:128082502
8564 8u https://doi.org/10.1177/1352458513475489

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy